• Exchange: Oslo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

DIAG:NO

0.910 NOK 0.010 1.09%

As of 10:25:00 ET on 07/31/2014.

Snapshot for DiaGenic ASA (DIAG)

Open: 0.930 Day's Range: 0.910 - 0.930 Volume: 139,600
Previous Close: 0.920 52wk Range: 0.467 - 2.000 1-Yr Rtn: -20.79%

Stock Chart for DIAG

No chart data available.
  • DIAG:NO 0.910
  • 1D
  • 1M
  • 1Y
0.920
Interactive DIAG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DIAG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. OBX -
Earnings Per Share (NOK) (ttm) -1.6214
Est. EPS (NOK) (12/2014) -
Est. PEG Ratio -
Market Cap (M NOK) 98.43
Shares Outstanding (M) 108.16
30 Day Average Volume 436,578
Price/Book (mrq) 1.7730
Price/Sale (ttm) 370.9707
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DIAG

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for DIAG

DiaGenic ASA is a biotechnology company. The Company has patents, pending and granted, for a method of preparing a standard diagnostic gene transcript pattern characteristic for a specific disease.

Ruben EkbratenInterim CEO/CFOMagnus SjogrenChief Medical Officer
Edith RianDir:OperationsMorten Sten JohansenDir:Intl Business
More Company Profile & Key Executives for DIAG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil